09/21/2026 14:04
Sultan bin Ahmed Announces Establishment of Jawaher Al Qasimi Humanitarian Innovation Centre in Indonesia With $1.6M Funding

His Highness Sheikh Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Humanitarian Envoy of The Big Heart Foundation (TBHF), has announced the establishment of the Jawaher Al Qasimi Humanitarian Innovation Centre at Universitas Gadjah Mada in Yogyakarta, Indonesia, with total funding of $1.6 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921973479/en/Sultan bin Ahmed announces establishment of Jawaher Al...

AFP video trailer opens WAN-IFRA’s 77th World News Media Congress

An AFP video trailer highlighting some of the major events covered by our newsroom over the past 12 months was screened at the opening of the 77th World News Media Congress organised by WAN-IFRA, the global association of news publishers and media organisations, held in Marseille from June 1 to 3.

An AFP video trailer highlighting some of the major events covered by our newsroom over the past 12 months was screened at the opening of the 77th World News Media Congress organised by WAN-IFRA, the global association of news publishers and media organisations, held in Marseille from June 1 to 3.
09/18/2026 10:38
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for M...

Boomi Announces 2026 APAC Customer Innovation Award Winners

Boomi, the data activation company for AI, announced today the winners of its2026 Asia Pacific (APAC) Customer Innovation Awards, recognised at its 2026Boomi...
Anglais
09/18/2026 10:58
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographi...

09/18/2026 10:49
GMKtec Unveils EVO-X5 Pro at IFA 2026 with AMD Ryzen(TM) AI Max Processors, Introducing the World's First Desktop AI Supercomputer Capable of Running a 300B-Parameter LLM Fully Offline

GMKtec officially unveiled the EVO-X5 Pro, its flagship desktop AI supercomputer, during its global launch event at IFA 2026, marking a major milestone in the evolution of local AI computing. Powered by AMD's latest Ryzen™ AI Max+ PRO 495 processor, the EVO-X5 Pro is the world's first desktop system capable of running a 300-billion-parameter large language model entirely offline, bringing enterprise-grade AI performance and data privacy to the desktop. EVO-X5 Pro launches on September 28. The l...